Skip to main content
SpringerLink
Log in

Ductal Adenocarcinoma

  • Chapter
Atlas of Exocrine Pancreatic Tumors

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cubilla AI, Fizgerald PJ (1984) Malignant neoplasms in tumors of the exocrine pancreas. Atlas of tumor pathology, Second Series Fascicle 19. AFIP, Washington DC, pp 109–233

    Google Scholar 

  2. Klöppel G (1984) Pancreatic non-endocrine tumours in pancreatic pathology. In: Klöppel G, Heitz PU (eds) Churchill Livingstone, Edinburgh, pp 79–113

    Google Scholar 

  3. Morohoshi T, Shimizu K, Kanda M (1991) Pancreatic tumors—their pathology and morpho-genesis. Jpn J Cancer Dig Org 1: 556–562

    Google Scholar 

  4. Saito Y (1990) Annual report of pancreatic cancers registered at Japan Pancreatic Society. Japanese Pancreatic Cancer Registration

    Google Scholar 

  5. Watanabe, S (1992) Epidemiology of pancreatic cancer in pancreatic tumor. In: Takeuchi M, Honnma T (eds) Nakayama-Shoten, Tokyo, pp 39–52

    Google Scholar 

  6. National Center for Health Statistics, U.S. Department of Health, Education, and Welfare (HSM721101), 1968

    Google Scholar 

  7. Boring CC, Squires TS, Tong T (1993) Cancer statistics. J Am Cancer Soc 43: 7–26

    CAS  Google Scholar 

  8. Fraumeni JF (1975) Cancer of the pancreas and biliary tract: Epidemiological considerations. Cancer Res 35: 3437–3446

    PubMed  Google Scholar 

  9. Kovi J, Heshmat MY (1973) Incidence of cancer in Negroes in Washington DC and selected African cities. Am J Epidemiol 95: 401–413

    Google Scholar 

  10. Mack TM, Paganini-Hill A (1981) Epidemiology of pancreatic cancer in Los Angeles. Cancer 47: 14741484

    Google Scholar 

  11. Moynan RW, Neerhour R, Johnson TS (1964) Pancreatic carcinoma in children: Case-report and review. J Pediatr 65: 711–720

    Google Scholar 

  12. Taxy JB (1976) Adenonarcinoma of the pancreas in childhood. Cancer 37: 1508–1518

    Article  PubMed  CAS  Google Scholar 

  13. Tsukimoto I, Watanabe K, Lin JB, Nakajima T (1973) Pancreatic carcinoma in children in Japan. Cancer 31: 1203–1207

    Article  PubMed  CAS  Google Scholar 

  14. Smith PE, Krementz ET, Reid RJ, Bulkin WJ (1967) An analysis of 600 with carcinoma of the pancreas. Surg Gynecol Obstet 124: 1288–1290

    PubMed  CAS  Google Scholar 

  15. Ivy EJ, Sarr MG, Reiman HM (1990) Nonendocrine cancer of the pancreas in patients under age forty years. Surgery 108: 481–487

    PubMed  CAS  Google Scholar 

  16. Andrén-Sandberg A (1989) Androgen influence on exocrine pancreatic cancer. Int J Pancreatol 7: 167–176

    Google Scholar 

  17. Longnecker DS, Roebuck BD, Yager JD Jr, Lilja HS, Siegmund B (1981) Pancreatic carcinoma in azaserine-treated rats: induction, classification and dietary modulation of incidence. Cancer 1562–1572

    Google Scholar 

  18. Lhoste F, Roebuck BD, Brinck-Johansen T,Longnecker DS (1987). Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats. Carcinogenesis 8: 699–703

    CAS  Google Scholar 

  19. Meijers M, Visser CJT, KlijnJGM, Lamberts SWJ, Garderen-Hoetmer FH, de Jong JA, Foeskens, Woutersen RA (1992) Effect of orchiectomy alone or in combination with testosterone and cyproterone acetate on exocrine pancreatic carcinogenesis in rats and hamsters. Int J Pancreatol 137–164

    Google Scholar 

  20. Corishley TP, Iqbal MJ, Wilkinson ML, Williams RS (1986) Androgen receptor in human normal and malignant pancreatic tissue and cell lines. Cancer 57: 1992–1995

    Article  Google Scholar 

  21. Greenway BA, Iqbal MJ, Johnson PJ, Williams RS (1982) Estrogen receptor proteins in malignant and fetal pancreas. Br J Surg 69: 293–296

    Google Scholar 

  22. Birt DF, Salmasi S, Pour PM (1981) Enhancement of experimental pancreatic cancer in Syrian golden hamsters by dietary fat. J Natl Cancer Inst 67: 1327–1332

    PubMed  CAS  Google Scholar 

  23. Hirayama T (1981) A large-scale cohort study on the relationship between diet and selected cancers of digestive organs. In: WB Bruce, P Correa, M Lipkin, SR Tannenbaum, TD Wilkins (eds) Banbury Report 7. Gastrointestinal cancer: endogenous factors. Cold Spring Harbor Laboratory, pp 409–429

    Google Scholar 

  24. Mack TM, Yu MC, Hanisch R, Henderson BE (1986) Pancreas cancer and smoking, beverage consumption and past medical history. J Natl Cancer Inst 76: 49–60

    PubMed  CAS  Google Scholar 

  25. Tomioka T, Andrén-Sandberg A, Fujii H, Egami H, Takiyama Y, Pour PM (1990) Comparative histopathological findings in the pancreas of cigarette smokers and non-smokers. Cancer Lett 55: 121–128

    Article  PubMed  CAS  Google Scholar 

  26. Feron VJ, Kuper CF, Spit BJ, Reuzel PG, Woutersen RA (1985) Glass fibers and vapor phase components of cigarette smoke as cofactors in experimental respiratory tract carcinogenesis. Carcinog Compr Sury 8: 93–118

    CAS  Google Scholar 

  27. Pour PM, Kazakoff K, Carlson K (1990) Inhibition of Streptozotocin-induced islet cell tumors and BOP-induced exogenous pancreatic tumors in Syrian hamsters. Cancer Res 50: 1634–1639

    PubMed  CAS  Google Scholar 

  28. Bell RH, Strayer DS (1983) Streptozotocin prevents development of nitrosamine-induced pancreatic cancer in the Syrian hamster. J Surg Oncol 24: 258–262

    Article  PubMed  CAS  Google Scholar 

  29. Cerosimo E, Pisters P, Pesola G, McDermot K, Bajorunas D, Brenann MF (1991) Insulin secretion and action in patient with pancreatic cancer. Cancer 67: 468–493

    Google Scholar 

  30. Permert J, Ihse I, Jorfeldt L, von Schenk H, Arnqvist HJ, Larsson J (1993) Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159: 101–107

    PubMed  CAS  Google Scholar 

  31. Permert J, Larsson J, Ihse I, Pour PM (1991) Diagnosis of pancreatic cancer. Alteration of glucose metabolism. Int J Pancreatol 9: 113–117

    Google Scholar 

  32. Permert J, Adrian TE, Jacobsson P, Jorfeld L, Fruin B, Larsson J (1993) Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor. Am J Surg 16: 119–124

    Google Scholar 

  33. The Registrar General’s Decennial Supplement (1985) England and Wales, 1951, Part II, Occupational Mortality. Her Majesty’s Stationary Office, London 20

    Google Scholar 

  34. Doerken H (1964) Einige Daten bei 280 Patienten mit Pankreaskrebs. Gastroenterologia 10: 47–77

    Google Scholar 

  35. Turner HM, Grace HG (1938) An investigation into cancer mortality among males in certain Sheffield trades. J Hyg 38: 90–103

    Article  CAS  Google Scholar 

  36. Mancuso TF, El-Attar AA (1967) Cohort study of workers exposed to betanaphtylamine and benzidine. J Occup Med 9: 277–285

    PubMed  CAS  Google Scholar 

  37. Anonymous (1974) Study finds cancer-woodworking tie. Eng News Rec 195: 15

    Google Scholar 

  38. Li FP, Fraumeni JF, Mantel N, Miller RW (1969) Cancer mortality among chemists. J Natl Cancer Inst 43: 1159–1164

    PubMed  CAS  Google Scholar 

  39. Pour PM, Runge RG, Birt D, Gingell R, Lawson T, Nagel D, Wallcave L (1981) Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer 47: 1573–1587

    Article  PubMed  CAS  Google Scholar 

  40. Palmiter RD, Chen HY, Messing A, Brinster RL (1985) SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumors in transgenic mice. Nature 316: 457–460

    Article  PubMed  CAS  Google Scholar 

  41. Sandgren EP, Quaife CL, Paulovich AG, Palmiter RD (1991) Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 88: 93–97

    Article  PubMed  CAS  Google Scholar 

  42. Ceci JD, Kovattch RM, Swing DA, Jones JM, Snow CM, Rosenberg MP, Jenkins NA, Copeland NG, Meisler MH (1991) Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas. Oncogene 6: 323–332

    PubMed  CAS  Google Scholar 

  43. Ghadirian P, Boyle P, Simard J, Baillargeon J, Maisonneuve P, Perret C (1991) Reported family aggregation of pancreatic cancer with a population-based case-control study in the francophone community in Montreal, Canada. Int J Pancreatol 10: 183–196

    Google Scholar 

  44. Pour PM (1990) Is there a link between chronic pancreatitis and pancreatic cancer. In: Beger H, Büchler M (eds) Chronic pancreatitis. Springer, Berlin Heidelberg New York, pp 106–112

    Chapter  Google Scholar 

  45. Mizumoto K, Tsutsumi M, Kitazawa S, Tsujita S, Nakayama M, Tsujii T, Kanehiro H, Nakajima Y, Nakano H, Konishi Y (1990) Intraductal carcinoma in a surgically resected pancreas with chronic pancreatitis. Int J Pancreatol 6:279–285

    Google Scholar 

  46. Morohoshi T, Kunimura T, Kanda M, Takahasi H, Yagi H, Shimizu K, Nakayoshi A, Asanuma K (1990) Multiple carcinomata associated with anomalous arrangement of the biliary and pancreatic duct system. Acta Pathol Jpn 40: 755–763

    PubMed  CAS  Google Scholar 

  47. Wynder EL, Mabuchi K, Maruchi N, Fortner JG (1973) Epidemiology of cancer of the pancreas. J Natl Cancer Inst 50: 645–667

    PubMed  CAS  Google Scholar 

  48. Pour PM, Donnelly T (1978) The effect of cholecystoduodenostomy and choledochostomy in pancreatic carcinogenesis. Cancer Res 38: 2048–2051

    PubMed  CAS  Google Scholar 

  49. Pour PM, Donnelly T, Stepan K (1983) Modification of pancreatic carcinogenesis in the hamster model. 5. Effect of partial pancreatico-colostomy. Carcinogenesis 10: 1327–1331

    Google Scholar 

  50. Konishi Y, Mizumoto K, Kitazawa S, Tsujiuchi T, Tsutsumi M, Kamano T (1990) Early ductal lesions of pancreatic carcinogenesis in animals and humans. Int J Pancreatol 7: 83–89

    PubMed  CAS  Google Scholar 

  51. Mizumoto K, Inagaki T, Koizumi M, Uemura M, Ogawa M, Kitazawa S, Tsutsumi M, Toyokawa M, Konishi Y (1988) Early pancreatic duct adenocarcinoma. Human Pathology 19: 242–244

    Article  PubMed  CAS  Google Scholar 

  52. Mukada T, Yamada S (1982) Dysplasia and carcinoma in situ of the exocrine pancreas. Tohoku J Exp Med 137: 115–124

    Article  PubMed  CAS  Google Scholar 

  53. Nakao A, Ichihara T, Nonami T, Harada A, Koshikawa T, Nakashima N, Nagura H, Takagi H (1989) Clinicohistopathologic and immunohistochemical studies of intrapancreatic development of carcinoma of the head of the pancreas. Ann Surg 209: 181–187

    Article  PubMed  CAS  Google Scholar 

  54. Pour PM, Sayed S, Sayed G, Wolf GL (1982) Hyperplastic, preneoplastic, and neoplastic lesions found in 83 human pancreases. Am J Clin Path 77: 137–152

    PubMed  CAS  Google Scholar 

  55. Pour PM (1984) Histogenesis of exocrine pancreatic cancer in the hamster model. Eviron Health Perspect 56: 229–243

    Article  CAS  Google Scholar 

  56. Pour PM (1988) Mechanism of pseudoductular (tubular) formation during pancreatic carcinogenesis in the hamster model. Am J Pathol 130: 335–344

    PubMed  CAS  Google Scholar 

  57. Toshkov I, Kirev T, Bannasch P (1991) Virus-induced pancreatic cancer in Guinea Fowl: An electron microscopic study. Int J Pancreatol 10: 51–64

    Google Scholar 

  58. Longnecker DS, Shinozuka H, Dekker A (1988) Focal acinar cell dysplasia in human pancreas. Cancer 45: 534–540

    Article  Google Scholar 

  59. Longnecker DS, Hashida Y, Shinozuka H (1980) Relationship of age to prevalence of focal acinar cell dysplasia in the human pancreas. J Natl Cancer Inst 65: 63–66

    PubMed  CAS  Google Scholar 

  60. Shinozuka H, Lee R, Dunn JL, Longneckaer DS (1980) Multiple atypical acinar cell nodules of the exocrine pancreas. Hum Pathol 11: 389–391

    Article  PubMed  CAS  Google Scholar 

  61. Tanaka T, Mori H, Williams GM (1988) Atypical and neoplastic acinar cell lesions of the pancreas in an autopsy study of Japanese patients. Cancer 61: 2278–2285

    Article  PubMed  CAS  Google Scholar 

  62. Kodama T, Mori W (1983) Atypical acinar cell nodules of the human pancreas. Acta Pathol Jpn 33: 701–714

    PubMed  CAS  Google Scholar 

  63. Pour PM (1985) Induction of unusual pancreatic neoplasms with morphologic similarity to human tumors and evidence for their ductal/ductular cell origin. Cancer 55: 2411–2416

    Article  PubMed  CAS  Google Scholar 

  64. Howard JM, Jordan GL Jr (1977) Cancer of the pancreas. Curr Probl Cancer 2: 5: 52

    Google Scholar 

  65. McDonald JS, Wilderlite L, Schein PS (1977) Biology, diagnosis and chemotherapeutic management of pancreatic malignancy. Adv Pharmacol Chemother 14: 107–142

    Article  Google Scholar 

  66. Moertel CG (1973) Exocrine pancreas. In: Holland JF, Frei E III (eds) Cancer medicine. Lea and Febiger, Philadelphia

    Google Scholar 

  67. Gambill EE (1970) Pancreatic and ampullary carcinoma: Diagnosis and prognosis in relation to symptoms, physical findings, and elapse of time as observed in 255 patients. South Med J 63:1119— 1122

    Google Scholar 

  68. Moossa AR, Lewis MH, Bowie JD (1980) Clinical features and diagnosis of pancreatic cancer. In: Moossa AR (ed) Tumors of the pancreas. Williams and Wilkins, Baltimore, pp 429–442

    Google Scholar 

  69. Fitzgerald PJ, Fortner JG, Watson RC, Schwartz MK, Sherlock P, Benua RS, Cubilla AL, Shottenfeld D, Miller D, Winawer SL, Lightdale CJ, Leidner SD, Nisselbaum JS, Menendez-Botet CJ, Poleski MM (1978) The value of diagnostic aids in detecting pancreas cancer. Cancer 41: 868–879

    Article  PubMed  CAS  Google Scholar 

  70. Go VL, Taylor WF, DiMagno EP (1981) Efforts at early diagnosis of pancreatic cancer: The Mayo Clinic experience. Cancer 3: 1698–1703

    Google Scholar 

  71. Tournat R, Allan BJ, White TT (1978) Cancer, pancreatitis, and detection of isoenzymes of DNASE, RNASE, and amylase. Clin Chem Acta 88: 345–353

    Google Scholar 

  72. Lake-Bakaar G, McKavnagh S, Summerfield JA (1979) Urinary immunoreactive trypsin excretion: a non-invasive screening test for pancreatic cancer. Lancet 2: 878–880

    Article  PubMed  CAS  Google Scholar 

  73. Nakane H, Yoshida M Murakami T (1979) Assessment of the clinical usefulness of serum ribonuclease assays: an indicator for the detection of pancreatic cancer. J Jpn Soc Gastroenterol 14: 55–62

    CAS  Google Scholar 

  74. Weickmann JL, Olson EM, Glitz DG (1984) Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer. Cancer Res 44: 1682–1687

    PubMed  CAS  Google Scholar 

  75. Douglas AP, Chandler C (1978) Galactosyl transferase isoenzymes for screening of patients with cancer and gluten-sensitive enteropathy. Gastroenterology 74: 11–20

    Google Scholar 

  76. Nishida K, Sugiura M, Yoshikawa T, Kondo M (1981) Enzyme immunoassay of pancreatic oncofetal antigen ( PUA) as a marker of pancreatic cancer. Gut 26: 450–455

    Google Scholar 

  77. Nevalainen TJ, Eskola JU, Aho AJ, Havia VT, Lövgren TN-E, Näntö V (1985) Immunoreactive phospholipase A2 in serum in acute pancreatitis and pancreatic cancer. Clin Chem 31: 1116–1120

    PubMed  CAS  Google Scholar 

  78. Hamano H, Hayakawa T, Kondo T (1987) Serum immunoreactive elastase in diagnosis of pancreatic diseases. A sensitive marker for pancreatic cancer. Dig Dis Sci 32: 50–56

    Google Scholar 

  79. Vezzadini P, Sterwiwi C, Gullo L, Bonora G, Campione O, Marrano P, Labo G (1984) Effect of secretin stimulation upon serum immunoreactive trypsin in patients with carcinoma of the pancreas. Surg Gynecol Obstet 158: 319–321

    PubMed  CAS  Google Scholar 

  80. Podolsky DK, Weiser MM (1978) Galactosyl transferase isozyme II: Correlation with extent of gastrointestinal malignancy and prediction of recurrence. Gastroenterology 74: 1140

    Google Scholar 

  81. Niitsu Y (1980) Serum ferritin and malignancy. Rinsho Ketsueki (Clin Hematol) 21: 1135–1143

    CAS  Google Scholar 

  82. Fateh-Moghadam A, Matel W, Nej meier D, Hannig C, Kristin M, Otte M (1978) The significance of beta 2-microglobulin and carcinoembryonic antigen in the diagnosis of the carcinoma of the pancreas. Klin Wochenschr 56: 267–270

    Article  PubMed  CAS  Google Scholar 

  83. Holyoke ED, Douglass HO, Goldrosen MH, Chu TM (1979) Tumor markers in pancreatic cancer. Semin Oncol 6: 347–356

    PubMed  CAS  Google Scholar 

  84. Nakamura RM, Plow EF, Edington TS (1978) Current status of carcinoembryonic antigen ( CEA) and CEA-S assays in the evaluation of neoplasms of the gastrointestinal tract. Ann Clin Lab Sci 8: 4–10

    Google Scholar 

  85. McIntire KR, Waldmann TA, Moertel GG, Go VLW (1975) Serum fetoprotein in pateints with neoplasm of the gastrointestinal tract. Cancer Res 35: 991–996

    PubMed  CAS  Google Scholar 

  86. Banwo O, Versey J, Hobbs JR (1974) New oncofetal antigen for human pancreas. Lancet 643645

    Google Scholar 

  87. Mihas AA (1978) Immunologic studies on a pancreatic oncofetal protein. J Natl Cancer Inst 60: 1439–1444

    PubMed  CAS  Google Scholar 

  88. Klavins JV (1981) Tumor markers of pancreatic carcinoma. Cancer 47: 1597–1601

    Article  PubMed  CAS  Google Scholar 

  89. Fujii Y, Albers GHR, Carre-Llopis A, Escribano MJ (1987) The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19–9. Br J Cancer 56: 495–500

    Article  PubMed  CAS  Google Scholar 

  90. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer JP (1974) Colorectal carcinoma antigen detected by hybridoma antibodies. Som Cell Genet 5: 957–972

    Article  Google Scholar 

  91. Lindholm L, HolmgrenJ, Svennerholm L, Fredman P, Nilsson O, Persson B, Myrvold H, Lagergrad T (1983) Monoclonal antibodies against gastrointestinal tumor-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immun 71: 178–181

    Article  CAS  Google Scholar 

  92. Bast RC, Freeny M, Lazarus H, Nadler LM, Colvin RB, Knall RC (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331–1337

    Article  PubMed  Google Scholar 

  93. Metzgar RS, Rodriguez N, Fin OJ, Lan MS, Daasch VN, Fernsten PD, Meyers WC, Sindelar WF, Sandler RS, Seigler HF (1984) Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 81: 5242–5246

    Article  PubMed  CAS  Google Scholar 

  94. Klug TL, Sattler MA, Colcher D, Schlom J (1986) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA72) on a novel pan-carcinoma antigen (TAG-72) Int J Cancer 38: 661–669

    CAS  Google Scholar 

  95. Herlyn M, Steplewski Z, Herlyn D, Koprowski H (1979) Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76: 1438–1442

    Google Scholar 

  96. Chung YS, Ho JJ, Kim YS, Tanaka H, Nakata B, Hiura A, Motoyoshi H, Satake K, Umeyama K (1987) The detection of human pancreatic cancer-associated antigen in the serum of cancer patients. Cancer 60: 1636–1643

    Article  PubMed  CAS  Google Scholar 

  97. Yuan SZ, Ho JJ, Yuan M, Kim YS (1985) Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies. Cancer Res 45: 6179–6187

    PubMed  CAS  Google Scholar 

  98. Loor R, Kuriyama M, Bodziak MLM, Inaji H, Douglass HO Jr, Berjian R, Nicolai JJ, Tytgat GN, Chu TM (1984) Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma. Cancer Res 44: 3604–3607

    PubMed  CAS  Google Scholar 

  99. Gold DV, Hollingsworth P, Kremer T, Nelson D (1983) Identification of a human pancreatic duct tissue-specific antigen. Cancer Res 43: 235–238

    PubMed  CAS  Google Scholar 

  100. Stenman UH, Huhtala ML, Koistinen R, Seppälä M (1982) Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int J Cancer 30: 53–57

    Article  PubMed  CAS  Google Scholar 

  101. Kawa S, Oguchi H, Kobayashi T, Tokoo M, Furuta S, Kanai M, Homma T (1991) Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype. Br J Cancer 64: 899–902

    Article  PubMed  CAS  Google Scholar 

  102. Wallach MK, Brown AS, Rosato EF (1978) Serum fucose as a monitor for recurrent malignancy. J Surg Oncol 10: 39–44

    Article  Google Scholar 

  103. Leveson SH, Russo AJ, Douglas HO, Goldrosen MR, Holyoke ED (1978) Diagnosis of pancreatic carcinoma using the leucocyte adherence inhibition microassay. Br J Surg 65: 360

    Google Scholar 

  104. Moossa AR, Levin B (1981) The diagnosis of “early” pancreatic cancer. The University of Chicago experience. Cancer 47: 1688–1697

    Google Scholar 

  105. Gelder FB, Reese CJ, Moossa AR, Hall T, Hunter R (1978) Studies on the oncofetal antigen, POA. Cancer 42: 1635–1645

    Google Scholar 

  106. Satake K (1991) Diagnosis of pancreatic cancer. Serological markers. Int J Pancreatol 9: 93–98

    PubMed  CAS  Google Scholar 

  107. Satake K, Chung Y-S, Umeyama K, Takeuchi T, Kim YS (1991) The possibility of diagnosing small pancreatic cancer (less than 4.0 cm) by measuring various serum tumor markers. Cancer 68: 149–152

    Article  PubMed  CAS  Google Scholar 

  108. Frebourg T, Bercoff E, Manchon N, Senant J, Basuyau J-P, Breton P, Janvresse A, Brunelle P, Bourreille J (1988) The evaluation of CA 19–9 antigen level in the early detection of pancreatic cancer. Cancer 62: 2287–2290

    Article  PubMed  CAS  Google Scholar 

  109. Tempero M, Takasaki H, Uchida E, Takiyama Y, Colcher D, Metzgar RS, Pour PM (1989) Co-expression of CA 19–9, DU-PAN-2, CAl25, and TAG-72 in pancreatic adenocarcinoma. Am J Surg Pathol 13: 89–95

    PubMed  Google Scholar 

  110. Del Favero G, Fabris C, Panucci A, Basso D, Plebani M, Baccaglini U, Leandro G, Burlina A, Naccarato R (1986) Carbohydrate antigen 19–9 (CA19–9) and carcinoembryonic antigen ( CEA) in pancreatic cancer. Bull Cancer (Paris) 73: 251–255

    Google Scholar 

  111. Satake K, Chung Y-S, Yokomatsu H, Nakata B, Sawada T, Nishiwaki H, Umeyama K (1991) Various tumor markers for small pancreatic cancer with special reference to the present status of pancreatic cancer in Japan and our experience over the past 2 years. Pancreas 6: 234–241

    Article  PubMed  CAS  Google Scholar 

  112. Beretta E, Malesci A, Zerbi A, Mariani A, Carlucci

    Google Scholar 

  113. White TT, Allan BJ, Schilling JJ, Miyashita H (1985) Human pancreatic secretory protein profiles in pancreas cancer and chronic pancreatitis. Dig Dis Sci 30: 200–203

    Article  PubMed  CAS  Google Scholar 

  114. White TT, Allan BJ, Schilling JJ, Miyashita H (1983) Human pancreatic secretory protein profiles in the search for tumor markers. Dig Dis Sci 28: 792–800

    Article  PubMed  CAS  Google Scholar 

  115. Scheele GA (1981) Human pancreatic cancer: analysis of proteins contained in pancreatic juice by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel electrophoresis. Cancer 47: 1513–1515

    Article  PubMed  CAS  Google Scholar 

  116. Rennel CL (1974) Diagnostic value of hypotonic duodenography. Am J Roentgenol Radium Ther Nuc Med 121: 256–263

    Google Scholar 

  117. Shirley DV (1974) Hypotonic duodenography in suspected pancreatic disease. Br J Radiol 47: 437–443

    Article  PubMed  CAS  Google Scholar 

  118. Pollock D, Taylor KJ (1981) Ultrasound scanning in patients with clinical suspicion of pancreatic cancer. Cancer 47: 1662–1665

    Article  PubMed  CAS  Google Scholar 

  119. Robbens AH, Gerzof SG, Pugatch RS (1979) Newer imaging techniques for diagnosis of pancreatic cancer. Semin Oncol 6: 332–343

    Google Scholar 

  120. Taylor KJ, Buchen PJ, Viscomi GN (1981) Ultrasonographic scanning of the pancreas: Prospective study of clinical results. Radiology 138: 211–213

    Google Scholar 

  121. DiMagno EP, Malagelada JR, Taylor WF, Go VLW (1977) A prospective comparison of current diagnostic tests for pancreatic cancer. N Engl J Med 297: 737–742

    Article  Google Scholar 

  122. Savarino V, Mansi C, Bistofi L, Rentilin P, Celle G (1983) Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage. Dig Dis Sci 28: 1078–1082

    Article  PubMed  CAS  Google Scholar 

  123. Redman HC (1981) Standard radiologie diagnosis and CT scanning in pancreatic cancer. Cancer 47: 1656–1661

    Article  PubMed  CAS  Google Scholar 

  124. Freeny PC (1989) Radiologie diagnosis and staging of pancreatic ductal adenocarcinoma. Radiol Clin North Am 27: 121–128

    PubMed  CAS  Google Scholar 

  125. Dreiling DA (1970) The early diagnosis of pancreatic cancer. Scand J Gastroenterol 6 [Suppl]: 115–122

    CAS  Google Scholar 

  126. Endo Y, Mori T, Tamuta H (1974) Cytodiagnosis of pancreatic malignant tumors by aspiration under direct vision, using duodenal fiberscope. Gastroenterology 67: 944–951

    PubMed  CAS  Google Scholar 

  127. Kameya S, Kuno N, Kasugai T (1981) The diagnosis of pancreatic cancer by pancreatic juice cytology. Acta Cytol 25: 354–360

    PubMed  CAS  Google Scholar 

  128. Yamada T, Murohisa B, Muto Y, Okamato K, Doi K, Tsuchiya R (1984) Cytologic detection of small pancreaticoduodenal and biliary cancers in the early developmental stage. Acta Cytol 28: 435–442

    PubMed  CAS  Google Scholar 

  129. Mithchell MK, Carney CN (1985) Cytologic criteria for the diagnosis of pancreatic carcinoma. Am J Clin Pathol 83: 171–176

    Google Scholar 

  130. Tatsuta M, Yamamura H, Yamamoto R, Okano Y, Takeshi M, Okuda S, Tamura H (1983) Significance of carcinoembryonic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer. Cancer 52: 1880–1885

    Article  PubMed  CAS  Google Scholar 

  131. Clouse ME, Gregg JA, Sedgwick CE (1975) Angiography vs pancreatography in diagnosis of carcinoma of the pancreas. Radiology 144: 605–610

    Google Scholar 

  132. Feinberg SB, Screiber DR, Goodale R (1977) Comparison of ultrasound pancreatic scanning and endoscopic retrograde cholangiopancreatograms: A retrospective study. J Clin Ultrasound 5: 96–100

    Google Scholar 

  133. Nakano S, Horiguchi Y, Takeda T (1974) Comparative diagnostic value of endoscopic pancreatography and pancreatic function tests. Scan J Gastroenterol 9: 383–389

    CAS  Google Scholar 

  134. Freeny PC, Ball TJ (1981) ERCP and PTC in evaluation of suspected pancreatic carcinoma-Diagnostic limitations and contemporary roles. Cancer 47: 1666–1678

    Article  PubMed  CAS  Google Scholar 

  135. Ishikawa O, Imaoka S, Ohigashi H, Nakaizumi A, Uehara H, Wada A, Nagumo CT, Yamamoto R, Sasaki Y, Iwanaga T (1992) A new method of intraoperative cytodiagnosis for more precisely locating the occult neoplasms of the pancreas. Surgery 111: 294–300

    PubMed  CAS  Google Scholar 

  136. Ferrucci JT, Wittenberg T, Sarno RH, Dreyfuss JR (1976) Fine needle transhepatic cholangiography: New approach to obstructive jaundice. AJR 127: 403–407

    Google Scholar 

  137. Okuda K, Tanikawa K, Emura T (1974) Nonsurgical percutaneous transhepatic cholangiography diagnostic significance in medical problems of the liver. Am J Dig Dis 19: 21–36

    Article  PubMed  CAS  Google Scholar 

  138. Pereiras R, Chiprut RO, Greenwald RA (1977) Percutaneous transhepatic cholangiography with the “skinny” needle. Ann Intern Med 562–568

    Google Scholar 

  139. Ferrucci JT, Wittenberg J (1978) CT biopsy of abdominal tumors. Aids for lesion localization. Radiology 129: 739–744

    Google Scholar 

  140. Kline TS, Neal MS (1978) Needle aspiration biopsy: A critical appraisal-eight years and 3267 specimens later. JAMA 239: 36–39

    Article  PubMed  CAS  Google Scholar 

  141. Yeh H (1981) Percutaneous fine needle aspiration biopsy of intraabdominal lesions with ultrasound guidance. Am J Gastroenterol 75: 148–152

    PubMed  CAS  Google Scholar 

  142. Kocjan G, Rode J, Lees WR (1989) Percutaneous fine needle aspiration cytology of the pancreas: advantages and pitfalls. J Clin Pathol 42: 341–347

    Article  PubMed  CAS  Google Scholar 

  143. Goodale RL, Gajl Peczalska K, Dressel T, Samuelson J (1981) Cytologic studies for the diagnosis of pancreatic cancer. Cancer 47: 1652–1655

    Article  PubMed  CAS  Google Scholar 

  144. Hovdenak N, Lees WR, Pereira J, Beilby JDW, Cotton PB (1982) Ultrasound-guided percutaneous fine needle aspiration cytology in pancreatic cancer. Br Med J 285: 1183–1184

    Article  CAS  Google Scholar 

  145. Ferrucci JF Jr, Wittenberg J, Margolies MN, Carry RW (1979) Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology 130: 345–356

    PubMed  CAS  Google Scholar 

  146. Smith FP, MacDonald JS, Schein PS (1980) Continuous seeding of pancreatic cancer by skinny-needle aspiration biopsy. Arch Intern Med 140: 855

    Article  PubMed  CAS  Google Scholar 

  147. Weger AR, Glaser KS, Schwab G, Oefner D, Bodner E, Auer GU, Mikuz G (1991) Quantitative nuclear DNA content in fine needle aspirates of pancreatic cancer. Gut 32: 325–328

    Article  PubMed  CAS  Google Scholar 

  148. Young NA, Villani MA, Khoury P, Naryshkin S (1991) Differential diagnosis of cystic neoplasms of the pancreas by fine-needle aspiration. Arch Pathol Lab Med 115: 571–577

    PubMed  CAS  Google Scholar 

  149. Ishida M (1983) Peritoneoscopy and pancreas biopsy in the diagnosis of pancreatic diseases. Gastrointest Endosc 29: 211–218

    Article  PubMed  CAS  Google Scholar 

  150. Ishida H, Domzono T, Furukawa Y (1984) Laparoscopy and biopsy in the diagnosis of malignant intra-abdominal tumors. Endoscopy 16: 140–142

    Article  PubMed  CAS  Google Scholar 

  151. Goldstein HM, Neiman HL, Bookstein JJ (1974) Angiography evaluation of pancreatic disease-A further appraisal. Radiology 112: 275–282

    PubMed  CAS  Google Scholar 

  152. Rosch J, Keller FS (1981) Pancreatic arteriography, transhepatic pancreatic venography and pancreatic venous sampling in diagnosis of pancreatic cancer. Cancer 47: 1679–1684

    Article  PubMed  CAS  Google Scholar 

  153. Tylen V, Arnesjo B (1973) Resectability and prognosis of carcinoma of the pancreas evaluated by angiography. Scand J Gastroenterol 8: 691–697

    PubMed  CAS  Google Scholar 

  154. Uden R (1976) Secretin and epinephrine combined in celiac angiography. Acta Radiol Diag 17: 17–40

    CAS  Google Scholar 

  155. MacGregor AHC, Hawkins IF Jr (1973) Selective pharmacodynamic angiography in the diagnosis of carcinoma of the pancreas. Surg Gynecol Obstet 137: 917–920

    PubMed  CAS  Google Scholar 

  156. Reichardt E, Lunderquist A, Tylen U (1978) Selective phlebography in carcinoma of the pancreas. Acta Radiol Diagn 19: 305–315

    CAS  Google Scholar 

  157. Montz R, Klapdor R, Kremer B, Rothe B (1985) Immunoszintigraphie and SPECT bei Patienten mit Pankreaskarzinom. Nucl Med 24: 232–237

    CAS  Google Scholar 

  158. Klöppel G (1986) Pathomorphology of pancreatic cancer: classification, histogenesis, localization, multifocal development, prognosis and differential diagnosis. In: Malfertheiner P, Ditschuneit H (eds) Diagnostic procedures in pancreatic disease. Springer Berlin Heidelberg New York

    Google Scholar 

  159. Japan Pancreatic Society (to be published) General rules for cancer of the pancreas, 4th edn. Mizumoto R (ed) Kanchara Shuppan, Tokyo

    Google Scholar 

  160. Kanai N, Nagaki S, Tanaka T (1987) Clear cell carcinoma of the pancreas. Acta Pathol Jpn 37: 1521–1526

    PubMed  CAS  Google Scholar 

  161. Hunterkoon M (1983) Oncocytic carcinoma of the pancreas. Cancer 51: 332–336

    Article  Google Scholar 

  162. Pour PM, Permert J, Mogaki M, Kazakoff K. Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biological significance. Am J Clin Pathol 100: 223–230

    Google Scholar 

  163. Kashiwabara K, Nakajima T, Shinkai H, Fukuda T, Oono Y, Kurabayashi Y, Kojima T, Nagamachi Y (1991) A case of malignant duct-islet cell tumor of the pancreas. Immunohistochemical and cyto-fluorometric study. Acta Pathol Jpn 41:636— 176. Pour PM, Takasaki H, Büchler M (1987) Immuno-641 logic aspects of acute and chronic pancreatitis.

    Google Scholar 

  164. Frantz VK. Tumours of the pancreas (1959) Atlas Verh Dtsch Ges Path 71:255–265 of tumor pathology, Section VII-Fascicles 27 177. Itzkowitz S, Kjeldsen T, Friera A, Hakomori S-I,and 28. Armed Forces Institute of Pathology, Yang U-S, Kim YS (1991) Expression of Tn,Washington DC, pp 96–141 sialosyl Tn, and T antigens in human pancreas.

    Google Scholar 

  165. Dawiskiba S, Pour PM, Stenram U, Sundler F, Gastroenterology 100:1691–1700 Andén-Sandberg fA (1992) Immunohistochemical 178. Kim YS, Itzkowitz SH, Yuan M, Chung Y-S,characterization of endocrine cells in experimental Satake K, Umeyama K, Hakomori S-I (1988) Le“exocrine pancreatic cancer in the Syrian golden and LeY antigen expression in human pancreatic hamster. Int J Pancreatol 11:97–104 cancer. Cancer Res 48: 475–482

    Google Scholar 

  166. Satake K, Shim K, Sowa M, Umeyama K (1985) 179. Itai S, Nishikata J, Yoneda T, Ohmori K, Yamabe Electron microscopic studies of human pancreatic

    Google Scholar 

  167. Arii S, Tobe T, Kannagi R (1991) Tissue adenocarcinoma. Eur J Surg Oncol 11:125 distribution of 2–3 and 2–6 sialyl Lewis A antigens 135 and significance of the ratio of two antigens for the

    Google Scholar 

  168. Sim K, Satake K, Sowa M, Umeyama K (1984) differential diagnosis of malignant and benign dis-Ultrastructural observations of human pancreatic orders of the digestive tract. Cancer 67:1576–1587 duct cell carcinoma. Nippon Geka Gakkai Zasshi

    Google Scholar 

  169. Schuessler MH, Pintado S, Welt S, Real FX, Xu 85:338–345 M, Melamed MR, Lloyd KO, Oettgen HF (1991)

    Google Scholar 

  170. Pour PM, Parsa I, Hauser R (1987) Evidence for Blood group and blood group-related antigens in partial exocrine acinar differentiation in experi normal pancreas and pancreas cancer: enhanced mentally induced pancreatic ductal/ductular cell expression of precursor type 1, Tn and sialyl-Tn in tumors. Int J Pancreatol 2:47–58 pancreas cancer. Int J Cancer 47: 180–187

    Google Scholar 

  171. Kern HF, Rausch U, Mollenhauer J (1986) Fine 181. Takasaki H, Tempero MA, Uchida E, Büchler M,structure of human pancreatic adenocarcinoma.

    Google Scholar 

  172. Ness MJ, Burnett DA, Metzgar RS, Colcher D,Go VLW, Gardner JD, Brooks FP, Lebenthal E, Schlom J, Pour PM (1988) Comparative studies on DiMagno EP, Scheele GA (eds) The exocrine the expression of tumor-associated glycoprotein pancreas: Biology, pathobiology, and diseases. (TAG-72), CA19–9 and UD-PAN-2 in normal,Raven, New York, pp 637–647 benign and malignant pancreatic tissue. Int J

    Google Scholar 

  173. Yamao K, Nakazawa S, Fujimoto M, Tsuda H, Cancer 42:681–686 Matsumoto K, Iwase T (1993) A mucous histo- 182.

    Google Scholar 

  174. Lan MS, Bast RC Jr, Colnaghi MI, Knapp RC,chemical and immunohistochemical study of pre- Colcher D, Schlom J, Metzgar RS (1987) Co-cancerous and neoplastic lesions in the human expression of human cancer-associated epitopes on pancreas. Int J Pancreatol 14: 37–44

    Google Scholar 

  175. mucin molecules. Int J Cancer 39:68–72

    Google Scholar 

  176. Klöppel G, Dreyer T, Lampe V, Kalthoff H, 183. Pour PM, Kazakoff K, Dulany K (1993) A new

    Google Scholar 

  177. Schmiegel WH, von Bülow M, Kern HF, Heitz PU multilabeling technique for simultaneous demon-(1984) Immunozytochemische Typisierung von stration of different islet cells in permanent slides.exokrinen Pankreastumoren and ihren Metastasen. Int J Pancreatol 13:139–142 Verh Dtsch Ges Pathol 68: 104–107

    Google Scholar 

  178. Klöppel G, Bosslet K, von Billow M, Kern HF

    Google Scholar 

  179. Pour PM, Burnett D. Uchida E (1985) Lectin (1984) Detection of different CEA epitopes in ductal binding affinities of induced pancreatic lesions in adenocarcinoma of the pancreas by monoclonal the hamster model. Carcinogenesis 6: 1775–1780

    Article  Google Scholar 

  180. antibodies (abstract) Dig Dis Sci 29:956

    Google Scholar 

  181. Haglund C, Roberts PJ, Nordling S, Ekblom P 185. Klöppel G, Fitzgerald PJ (1986) Pathology of non-(1984) Expression of laminin in pancreatic neo endocrine pancreatic tumors. In: Go VLW, Gardner plasms and in chronic pancreatitis. Am J Surg JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele Pathol 8:669–676 GA (eds) The exocrine pancreas: Biology, patho

    Google Scholar 

  182. Pour PM, Tempero MA, Takasaki H, Uchida E, biology, and diseases. Raven, New York, pp 649-Takiyama Y, Burnett DA, Steplewski Z (1988) 674 Expression of blood-group related antigens ABH, 186.

    Google Scholar 

  183. Morohoshi T, Kanda M, Horle A, et al. (1987)Lewis A, Lewis B, Lewis X, Lewis Y and CA19–9 in Immunocytochemical markers of uncommon pan-pancreatic cancer cells in comparison with the creatic tumors. Cancer 59:739–747 patient’s blood group type. Cancer Res 48: 187.

    Google Scholar 

  184. Kiyohara H, Egami H, Kako H, Shibata Y, Murata 5422–5426 K, Ohshima S, Sei K, Suko S, Kurano R, Ogawa

    Google Scholar 

  185. Itzkowitz SH, Yuan M, Ferrell LD, Ratcliffe RM, M (1993) Immunohistochemical localization of Chung Y-S, Satake K, Umeyama K, Jones RT, Group II phospholipase A2 in human pancreatic

    Google Scholar 

  186. Kim YS (1987) Cancer-associated alterations of carcinoma. Int J Pancreatol 13:49–57 blood group antigen expression in the human pan

    Google Scholar 

  187. Ohta T, Nagakawa T, Tsukioka Y, Mori K, creas. J NCI 79: 425–433

    Google Scholar 

  188. Kayahara M, Kanno M, Ueno K, Miyazaki I, Terada T, Nakanuma Y (1992) Argyrophilic nuclear organizer region counts in exocrine pancreatic tumors. Int J Pancreatol 12: 201–209

    PubMed  Google Scholar 

  189. Baisch H, Klöppel G, Reinke B (1990) DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma. Flow cytometric study of formalin-fixed paraffin-embedded tissue. Virchows Arch [A] 417: 145–150

    Google Scholar 

  190. Yoshimura T, Manabe T, Suwa H, Imamura T, Wang Z, Ohshio G, Yamabe H, Matsumoto M, Ogasahara K, Takasan H (1993) Nuclear content as a prognostic predictor in carcinoma of the pancreas. Int J Pancreatol 14: 29–36

    PubMed  CAS  Google Scholar 

  191. Sciallero S, Giaretti W, Geido E, Bonelli L, Zhankui L, Saccomanno S, Zeraschi E, Pugliese V (1993) DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer. Int J Pancreatol 14: 21–28

    PubMed  CAS  Google Scholar 

  192. Allison DC, Bose KK, Hruban RH, Piantadosi S, Dooley WC, Boitnott JK, Cameron JL (1991) Pancreatic cancer cell DNA constant correlates with long-term survival after pancreaticoduodenectomy. Ann Surg 214: 648–656

    Article  PubMed  CAS  Google Scholar 

  193. Alanen KA, Joensuu H, Klemi PJ (1991) Letters to the editors, Virchows Arch [A] 419: 255–256

    Article  CAS  Google Scholar 

  194. Eskelinen M, Lipponen P, Collan Y, Marin S, Alhava E, Nordling S (1991) Relationship between DNA ploidy and survival in patients with exocrine pancreatic cancer. Pancreas 6: 90–95

    Article  PubMed  CAS  Google Scholar 

  195. Herrera M, van Heerden JA, Katzmann JA, Weiland LH, Nagorney DM, Ilstrup D (1992) Evaluation of DNA nuclear pattern as a prognostic determinant in resected pancreatic ductal adenocarcinoma. Ann Surg 215: 120–124

    Article  PubMed  CAS  Google Scholar 

  196. Lipponen PK, Eskelinen MJ, Collan Y, Marin S, Alhava E (1990) Volume correlated mitotic index in human pancreatic cancer. Relation to histologic grade, clinical stage, and prognosis. Scan J Gastroenterol 251: 548–554

    Google Scholar 

  197. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Büchler M, Beger HG (1992) Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 90: 1352–1360

    Article  PubMed  CAS  Google Scholar 

  198. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M (1987) Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 48: 161–164

    Google Scholar 

  199. Sainsbury JRC, Sherbet GV, Farndon JR, Harris AL (1985) Epidermal growth factor receptors in human brain tumors. Lancet i: 364–366

    Google Scholar 

  200. Yamanaka Y, Onda M, Uchida E, Kobayashi T, Sasajima K, Tokunaga A, Yajiri T, Egami K, Asano G (1990) Immunohistochemical study on epidermal growth factor and its receptor in human pancreatic carcinoma. Jpn J Gastroenterol 87: 1544–1550

    CAS  Google Scholar 

  201. Hoorens A, Lemoine N, McLellan E, Morohoshi T, Kamisawa T, Heitz PU, Stamm B, Rüschoft J, Wiedenmann B, Klöppel G (1993) Pancreatic tumors with acinar cell differentiation: their histologic, immunocytochemical, ultrastructural and molecular biological spectrum. Am J Pathol 143: 685–698

    PubMed  CAS  Google Scholar 

  202. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR (1991) Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 163: 111–116

    Article  PubMed  CAS  Google Scholar 

  203. Wakita K, Ohyanagi H, Yamamoto K, Tokuhisa T, Saitoh Y (1992) Overexpression of c-Ki-ras and c-fos in human pancreatic carcinoma. Int J Pancreatol 11: 43–47

    PubMed  CAS  Google Scholar 

  204. Smit THBMV, Boot JMA, Bos LJ (1988) K-ras codon 12 mutations occurs very frequently in pancreatic adenocarcinomas. Nucl Acids Res 10: 7773–7782

    Google Scholar 

  205. Yanagisawa A, Kato Y, Ohtake K, Kitagawa T, Ohashi K, Hori M, Takagi K, Sugano H (1991) c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 82: 1057–1060

    Google Scholar 

  206. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T (1993) Detection of point mutations in the Kirsten-ras oncogene provides evidenace for the multicentricity of pancreatic carcinoma. Ann Surg 217: 138–143

    Article  PubMed  CAS  Google Scholar 

  207. Kato O, Kuno N, Kasugai T (1979) Pancreatic carcinoma difficult to differentiate from duodenal carcinoma. Am J Gastroenterol 71: 74–77

    PubMed  CAS  Google Scholar 

  208. Yamaguchi K, Tanaka M (1992) Groove pancreatitis masquerading as pancreatic carcinoma. Am J Surg 163: 312–316

    Article  PubMed  CAS  Google Scholar 

  209. Yanagisawa, A Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, Kato Y (1993) Frequent cKi-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 53: 953–956

    Google Scholar 

  210. Baylor SM, Berg JW (1973) Cross-classification and survival characteristics of 5000 cases of cancer of the pancreas. J Surg Oncol 5: 335–358

    Article  PubMed  CAS  Google Scholar 

  211. Tannapfel A, Wittekind C, Hünefeld G (1992) Ductal adenocarcinoma ofthe pancreas. Histopathological features and prognosis. Int J Pancreatol 12: 145–152

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Eppley Institute for Research in Cancer; Department of Pathology and Microbiology, University of Nebraska Medical Center, 68198-6805, Omaha, NE, USA

    Parviz M. Pour M.D.

  2. Department of Oncological Pathology, Cancer Center, Nara Medical College, Kashihara, Nara, 634, Japan

    Yoichi Konishi M.D.

  3. Department of Pathology, Academy Hospital Jette, Free University of Brussels, 1090, Brussels, Belgium

    Günter Klöppel M.D.

  4. Department of Pathology, Dartmouth Medical School, 03756, Hanover, NH, USA

    Daniel S. Longnecker M.D.

Authors
  1. Parviz M. Pour M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoichi Konishi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Günter Klöppel M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel S. Longnecker M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Eppley Institute for Research in Cancer; Department of Pathology and Microbiology, University of Nebraska Medical Center, 68198-6805, Omaha, NE, USA

    Parviz M. Pour M.D.

  2. Department of Oncological Pathology, Cancer Center, Nara Medical College, Kashihara, Nara, 634, Japan

    Yoichi Konishi M.D.

  3. Department of Pathology, Academy Hospital Jette, Free University of Brussels, 1090, Brussels, Belgium

    Günter Klöppel M.D.

  4. Department of Pathology, Dartmouth Medical School, 03756, Hanover, NH, USA

    Daniel S. Longnecker M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Pour, P.M., Konishi, Y., Klöppel, G., Longnecker, D.S. (1994). Ductal Adenocarcinoma. In: Pour, P.M., Konishi, Y., Klöppel, G., Longnecker, D.S. (eds) Atlas of Exocrine Pancreatic Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68311-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68311-7_8

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68313-1

  • Online ISBN: 978-4-431-68311-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation